Breaking News Instant updates and real-time market news.

CERU

Cerulean

$0.68

-0.0168 (-2.41%)

08:05
10/19/16
10/19
08:05
10/19/16
08:05

Cerulean announces $20M firm commitment at-the-market agreement with Aspire

Cerulean Pharma announced that it has entered into a $20M common stock purchase agreement and a registration rights agreement with Aspire Capital Fund, a Chicago-based institutional investor. These agreements constitute a firm commitment at-the-market equity facility. Immediately following the execution of the Purchase Agreement, Aspire purchased 800,000 shares of common stock for $1.25 per share. Cerulean has the right to sell up to the remaining $19.0 million of its common stock to Aspire over a 24-month period, at prices based on a formula linked to current market prices at the time of each sale. Aspire has the obligation to purchase common stock from Cerulean in amounts and timing determined by Cerulean in its sole discretion, subject to certain limits. The Purchase Agreement does not contain any restrictions on the use of any of the proceeds, financial or business covenants, restrictions on future financings, rights of first refusal, participation rights, penalties or liquidated damages. In connection with entering into the Purchase Agreement, Cerulean issued 700,000 commitment shares to Aspire. There are no warrants associated with this transaction. The Purchase Agreement may be terminated by Cerulean at any time, at its discretion, without any cost.

CERU Cerulean
$0.68

-0.0168 (-2.41%)

08/18/16
JMPS
08/18/16
DOWNGRADE
JMPS
Market Perform
Cerulean downgraded to Market Perform from Outperform at JMP Securities
JMP Securities analyst Michael King downgraded Cerulean after the company announced negative top-line results from a study of its CRLX101 drug in patients with advanced renal cell carcinoma. Noting that the study indicated that there was no difference between the results of patients taking CRLX101 and those taking the standard treatment, King says that the stock is fairly valued at current levels.
08/18/16
ROTH
08/18/16
NO CHANGE
Target $2.5
ROTH
Buy
Roth Capital trims Cerulean price target, but remains a buyer
Roth Capital analyst Joseph Pantginis lowered his price target for Cerulean to $2.50 from $9 after the company's Phase 2 clinical trial of CRLX101 for advanced renal cell carcinoma, or RCC, demonstrated no statistically significant difference. Nonetheless, with a platform technology providing long-term pipeline fill and improvements in tumor targeting, Pantginis believes Cerulean remains an attractive opportunity despite the failure in late-stage RCC. He reiterates a Buy rating on the shares.
08/18/16
08/18/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Twitter (TWTR) downgraded to Sell from Hold at Evercore ISI with analyst Ken Sena saying he sees "more risk than reward" ahead of Snapchat's anticipated monetization ramp this fall. 2. Ambev (ABEV) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Jeronimo De Guzman saying valuation is full and sees difficult near-term trends ahead given lower disposable income, volume weakness, and lower realized pricing. 3. Icahn Enterprises (IEP) downgraded to Sell from Neutral at UBS saying the company's net asset value, despite declining 49% since second quarter of 2015, seems to include optimistic valuations. 4. Cerulean (CERU) downgraded to Neutral from Buy at Janney Capital, to Market Perform from Outperform at Leerink, and to Market Perform from Outperform at JMP Securities. 5. Magellan Midstream (MMP) downgraded to Underweight at Morgan Stanley with analysts led by Tom Abrams citing a relatively high valuation as the number of lower multiple investment choices has increased. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/18/16
WEDB
08/18/16
DOWNGRADE
WEDB
Neutral
Cerulean downgraded to Neutral from Outperform at Wedbush

TODAY'S FREE FLY STORIES

08:15
06/28/17
06/28
08:15
06/28/17
08:15
General news
Energy Action: NYMEX »

Energy Action: NYMEX…

08:15
06/28/17
06/28
08:15
06/28/17
08:15
General news
International Trade in Goods Balance to be reported at 08:30 »

May International Trade…

LNCE

Snyder's-Lance

$34.88

-1.27 (-3.51%)

08:14
06/28/17
06/28
08:14
06/28/17
08:14
Hot Stocks
Snyder's-Lance appoints Brian Driscoll as CEO »

Snyder's-Lance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MON

Monsanto

$117.25

-0.55 (-0.47%)

08:14
06/28/17
06/28
08:14
06/28/17
08:14
Earnings
Monsanto sees FY17 ongoing EPS $4.50-$4.90, consenus $4.89 »

The company confirms EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MON

Monsanto

$117.25

-0.55 (-0.47%)

, BAYRY

Bayer

$137.59

0.89 (0.65%)

08:14
06/28/17
06/28
08:14
06/28/17
08:14
Earnings
Monsanto reports Q3 ongoing EPS $1.93, consensus $1.76 »

Reports Q3 revenue…

MON

Monsanto

$117.25

-0.55 (-0.47%)

BAYRY

Bayer

$137.59

0.89 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

TYG

Tortoise Energy

$29.13

-0.14 (-0.48%)

08:13
06/28/17
06/28
08:13
06/28/17
08:13
Upgrade
Tortoise Energy rating change  »

Tortoise Energy upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBT

Global Blood Therapeutics

$27.50

-0.4 (-1.43%)

08:12
06/28/17
06/28
08:12
06/28/17
08:12
Hot Stocks
Global Blood Therapeutics receives EMA PRIME designation for GBT440 »

Global Blood Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNF

UniFirst

$139.05

-1.25 (-0.89%)

08:12
06/28/17
06/28
08:12
06/28/17
08:12
Earnings
UniFirst sees FY17 EPS $4.85-$5.00, consensus $5.01 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

UNF

UniFirst

$139.05

-1.25 (-0.89%)

08:11
06/28/17
06/28
08:11
06/28/17
08:11
Earnings
UniFirst reports Q3 adj. EPS $1.36, consensus $1.34 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MNRO

Monro Muffler

$45.15

-0.8 (-1.74%)

08:10
06/28/17
06/28
08:10
06/28/17
08:10
Hot Stocks
Monro Muffler appoints Ponton to succeed Van Heel as CEO »

Monro Muffler Brake…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUVA

NuVasive

$75.54

-1.15 (-1.50%)

08:08
06/28/17
06/28
08:08
06/28/17
08:08
Recommendations
NuVasive analyst commentary  »

NuVasive price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 15

    Aug

CA

CA Technologies

$34.62

-0.19 (-0.55%)

08:08
06/28/17
06/28
08:08
06/28/17
08:08
Recommendations
CA Technologies analyst commentary  »

Potential CA Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPO

XPO Logistics

$60.84

-0.32 (-0.52%)

08:06
06/28/17
06/28
08:06
06/28/17
08:06
Initiation
XPO Logistics initiated  »

XPO Logistics initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jul

CBI

CB&I

$20.03

5.63 (39.10%)

08:04
06/28/17
06/28
08:04
06/28/17
08:04
Hot Stocks
CB&I awarded contract by Shurtan Gas Chemical Complex »

CB&I announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMNX

Luminex

$20.92

-0.3 (-1.41%)

08:04
06/28/17
06/28
08:04
06/28/17
08:04
Hot Stocks
Luminex receives CE-IVD mark for ARIES Norovirus Assay »

Luminex announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

NVIV

InVivo Therapeutics

$2.75

0.2 (7.84%)

08:04
06/28/17
06/28
08:04
06/28/17
08:04
Hot Stocks
InVivo Therapeutics reports two patients in study improve in INSPIRE assessments »

InVivo Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

MSA

MSA Safety

$79.73

0.44 (0.55%)

08:03
06/28/17
06/28
08:03
06/28/17
08:03
Hot Stocks
MSA Safety to acquire Globe Holding Company for $215M in cash »

MSA Safety announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCA

HCA Holdings

$86.01

-0.61 (-0.70%)

07:59
06/28/17
06/28
07:59
06/28/17
07:59
Initiation
HCA Holdings initiated  »

HCA Holdings initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STT

State Street

$87.90

0.08 (0.09%)

07:59
06/28/17
06/28
07:59
06/28/17
07:59
Upgrade
State Street rating change  »

State Street upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

OLN

Olin Corp.

$29.31

0.29 (1.00%)

07:58
06/28/17
06/28
07:58
06/28/17
07:58
Recommendations
Olin Corp. analyst commentary  »

Cowen calls Olin Corp. a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSKE

Daseke

$10.40

0.09 (0.87%)

07:57
06/28/17
06/28
07:57
06/28/17
07:57
Recommendations
Daseke analyst commentary  »

Daseke revenue synergies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRU

TransUnion

$43.52

-0.78 (-1.76%)

07:57
06/28/17
06/28
07:57
06/28/17
07:57
Recommendations
TransUnion analyst commentary  »

TransUnion guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

COST

Costco

$159.26

-0.94 (-0.59%)

, AMZN

Amazon.com

$976.78

-17.2 (-1.73%)

07:56
06/28/17
06/28
07:56
06/28/17
07:56
Recommendations
Costco, Amazon.com analyst commentary  »

Costco weakness a buying…

COST

Costco

$159.26

-0.94 (-0.59%)

AMZN

Amazon.com

$976.78

-17.2 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 23

    Aug

PYPL

PayPal

$52.73

-1.01 (-1.88%)

07:55
06/28/17
06/28
07:55
06/28/17
07:55
Recommendations
PayPal analyst commentary  »

PayPal shares could…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

07:55
06/28/17
06/28
07:55
06/28/17
07:55
General news
N.Y. FX Outlook »

N.Y. FX Outlook: The…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.